Finance

Lists
Why is SKYE down 2,52%?
Dive Deeper
SKYE:NASDAQ
Skye Bioscience Inc
1,55 US$
-2,52%
(-0,040) 1D
1,55 US$
0,00% (0,00)
After hours
Closed: 16 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SKYE...
Open
1,60 US$
High
1,60 US$
Low
1,54 US$
Mkt. cap
6,86 მლნ.
Avg. vol.
65,34 ათ.
Volume
20,20 ათ.
52-wk high
13,28 US$
52-wk low
1,50 US$
EPS
-10,18 US$
Beta
2,86
Shares outstanding
4,43 მლნ.
No. of employees
2
Open
1,60 US$
High
1,60 US$
Low
1,54 US$
Mkt. cap
6,86 მლნ.
Avg. vol.
65,34 ათ.
Volume
20,20 ათ.
52-wk high
13,28 US$
52-wk low
1,50 US$
EPS
-10,18 US$
Beta
2,86
Shares outstanding
4,43 მლნ.
No. of employees
2
News stories
From web sources and news partners
About Skye Bioscience Inc
CEO-
Employees2
Founded2011
Headquarters-
Sector-
Websiteskyebioscience.com
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
20,00 US$
+1 190,3%
05/21/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
6,00 US$
+287,1%
05/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
05/12/2026
Jay Olson
Oppenheimer
Buy
Maintained
10,00 US$
+545,2%
03/11/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
2,00 US$
+29%
03/10/2026
Albert Lowe
Craig-Hallum
Hold
Maintained
-
-
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,36 მლნ.
11,47 მლნ.
7,94 მლნ.
3,94 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,91 მლნ.
3,43 მლნ.
4,74 მლნ.
3,87 მლნ.
Operating expense
13,26 მლნ.
14,90 მლნ.
12,67 მლნ.
7,81 მლნ.
Total operating expenses
13,26 მლნ.
14,90 მლნ.
12,67 მლნ.
7,81 მლნ.
Operating income
-13,26 მლნ.
-14,90 მლნ.
-12,67 მლნ.
-7,81 მლნ.
Other non operating income
-
-502,00
-2,41 ათ.
-
EBT including unusual items
-12,75 მლნ.
-14,44 მლნ.
-12,51 მლნ.
-10,78 მლნ.
EBT excluding unusual items
-12,85 მლნ.
-14,62 მლნ.
-12,51 მლნ.
-7,71 მლნ.
Income tax expense
-
-
-
3,40 ათ.
Effective tax rate
-
-
-
-0,03%
Other operating expenses
-
-
-
-
Net income
-12,75 მლნ.
-14,44 მლნ.
-12,51 მლნ.
-10,79 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-2,59
-2,95
-2,56
-1,55
Interest and investment income
418,47 ათ.
274,10 ათ.
169,62 ათ.
103,21 ათ.
Interest expense
-
-
-2,20 ათ.
-3,30 ათ.
Net interest expenses
418,47 ათ.
274,10 ათ.
167,42 ათ.
99,91 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,09 მლნ.
-14,72 მლნ.
-12,50 მლნ.
-7,65 მლნ.
Gain or loss from assets sale
-91,40 ათ.
-179,99 ათ.
7,62 ათ.
411,46 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები